article thumbnail

From Hype to Reality: Top Trends Driving the Future of Generative AI

SCIP

Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine. By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge.

SCIP 40
article thumbnail

Ser CIO en 2025: estos serán los principales desafíos tecnológicos

CIO

En 2025, nuestra empresa se enfocar en varias iniciativas clave para impulsar la investigacin y el desarrollo de nuevas molculas , explica Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed.

Biotech 183
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top IPOs to Watch in 2025 | APAC Region

Alpha Sense BI

With a 5,500 member R&D team and 14 research centers, Hengrui has positioned itself as a global leader in biotech innovation, making this one of the most significant healthcare IPOs in APACs 2025 market. LG Electronics India Industry : Consumer Electronics Expected Valuation : 15,000 crore ($1.8

article thumbnail

Biotech and Pharma M&A: 2025 Outlook

Alpha Sense BI

Concurrently, smaller biotech firms and midsized companies offering promising innovations, particularly in high-demand therapeutic areas such as oncology, immunology, neuroscience, and cardio-metabolic conditions, are expected to become highly attractive targets. How will tariff policies play out?

Biotech 59
article thumbnail

Scaling a medical device company: A CIO’s digital transformation journey

CIO

I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. So, it’s a little bit of yin and yang in my in my life, but I believe in data assurance. Then I started working.

Biotech 183
article thumbnail

Deep tech disruption: How advanced technologies are transforming businesses

CIO

Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. Many Fortune 500 companies now invest in AI, robotics and biotech startups through corporate venture arms, gaining insights and strategic advantage.

article thumbnail

Harnham Seeks Senior Competitive Intelligence Manager for Biotech Company

ArchIntel

The Greater Boston Area-based senior manager’s primary responsibilities include monitoring competitor and customer activities, direct threat assessments , and ensuring that the biotech company is in an optimal competitive position in terms of its product releases.

Biotech 104